Recent advances in cellular models for discovering prion disease therapeutics

References

• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216 April:6801762.
   Web of Science ®Google Scholar
• Prusiner SB. Shattuck lecture–neurodegenerative diseases and prions. N Engl J Med. 2001;344(20):1516–1526.
   PubMed Web of Science ®Google Scholar
• Stahl N, Borchelt DR, Hsiao K, et al. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell. 1987;51(2):229–240.
   PubMed Web of Science ®Google Scholar
• Sigurdson CJ, Bartz JC, Glatzel M. Cellular and molecular mechanisms of prion disease. Annu Rev Pathol. 2019;14(1):497–516.
   PubMed Web of Science ®Google Scholar
• Prodromidou K, Papastefanaki F, Sklaviadis T, et al. Functional cross-talk between the cellular prion protein and the neural cell adhesion molecule is critical for neuronal differentiation of neural stem/precursor cells. Stem Cells. 2014 Jun;32(6):1674–1687.
   PubMed Web of Science ®Google Scholar
• Caiati MD, Safiulina VF, Fattorini G, et al. PrPC controls via protein kinase A the direction of synaptic plasticity in the immature hippocampus. J Neurosci. 2013 Feb 13;33(7):2973–2983.
   PubMed Web of Science ®Google Scholar
• Kuffer A, Lakkaraju AK, Mogha A, et al. The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6. Nature. 2016 Aug 25;536(7617):464–468.
   PubMed Web of Science ®Google Scholar
• Caughey B. Interactions between prion protein isoforms: the kiss of death? Trends Biochem Sci. 2001;26(4):235–242.
   PubMed Web of Science ®Google Scholar
• Ironside JW, Ritchie DL, Head MW. Prion diseases. Handb Clin Neurol. 2017;145:393–403.
   PubMedGoogle Scholar
• Houston F, Andreoletti O. Animal prion diseases: the risks to human health. Brain Pathol. 2019 Mar;29(2):248–262.
   PubMed Web of Science ®Google Scholar
• Scialò C, De Cecco E, Manganotti P, et al. Prion and prion-like protein strains: deciphering the molecular basis of heterogeneity in neurodegeneration. Viruses. 2019;11(3):1–37.
   Web of Science ®Google Scholar
• Carta M, Aguzzi A. Molecular foundations of prion strain diversity. Curr Opin Neurobiol. 2022 Feb;72:22–31.
   PubMed Web of Science ®Google Scholar
• Hill AF, Collinge J. Prion strains and species barriers. Contrib Microbiol. 2004;11:33–49.
   PubMedGoogle Scholar
• Berry DB, Lu D, Geva M, et al. Drug resistance confounding prion therapeutics. Proc Natl Acad Sci USA. 2013;110(44):E4160–9.
   PubMed Web of Science ®Google Scholar
• Ghaemmaghami S, Ahn M, Lessard P, et al. Continuous quinacrine treatment results in the formation of drug-resistant prions. Plos Pathog. 2009;5(11):e1000673.
   PubMed Web of Science ®Google Scholar
• Colini Baldeschi A, Vanni S, Zattoni M, et al. Novel regulators of PrP(C) expression as potential therapeutic targets in prion diseases. Expert Opin Ther Targets. 2020 Aug;24(8):759–776.
   PubMed Web of Science ®Google Scholar
• Geschwind MD, Kuo AL, Wong KS, et al. Quinacrine treatment trial for sporadic creutzfeldt-Jakob disease. Neurology. 2013;81(23):2015–2023.
   PubMed Web of Science ®Google Scholar
• Giles K, Berry DB, Condello C, et al. Different 2-aminothiazole therapeutics produce distinct patterns of scrapie prion neuropathology in mouse brains. J Pharmacol Exp Ther. 2015;355(1):2–12.
   PubMed Web of Science ®Google Scholar
• Clarke MC, Haig DA. Evidence for the multiplication of scrapie agent in cell culture. Nature. 1970;225(5227):100–101.
   PubMed Web of Science ®Google Scholar
• Chandler RL. Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet. 1961;1(7191):1378–1379.
   PubMed Web of Science ®Google Scholar
• van der Merwe J, Aiken J, Westaway D, et al. The standard scrapie cell assay: development, utility and prospects. Viruses. 2015 January 16 7(1):180–198.
   PubMed Web of Science ®Google Scholar
• Oelschlegel AM, Geissen M, Lenk M, et al. A bovine cell line that can be infected by natural sheep scrapie prions. Plos One. 2015;10(1):1–15.
   Web of Science ®Google Scholar
• Krance SH, Luke R, Shenouda M, et al. Cellular models for discovering prion disease therapeutics: progress and challenges. J Neurochem. 2020 Apr;153(2):150–172.
   PubMed Web of Science ®Google Scholar
• Bosque PJ, Prusiner SB. Cultured cell sublines highly susceptible to prion infection. J Virol. 2000;74(9):4377–4386.
   PubMed Web of Science ®Google Scholar
• Ghaemmaghami S, Phuan P-W, Perkins B, et al. Cell division modulates prion accumulation in cultured cells. Proc Nat Acad Sci. 2007;104(46):17971–17976.
   PubMed Web of Science ®Google Scholar
• Pineau H, Sim VL. From cell culture to organoids-model systems for investigating prion strain characteristics. Biomolecules. 2021;11(1):1–24.
   Web of Science ®Google Scholar
• Kocisko DA, Baron GS, Rubenstein R, et al. New inhibitors of scrapie-associated prion protein formation in a library of 2,000 drugs and natural products. J Virol. 2003;77(19):10288–10294.
   PubMed Web of Science ®Google Scholar
• Kocisko DA, Caughey B. Searching for anti‐prion compounds: cell‐based high‐throughput in vitro assays and animal testing strategies. amyloid, prions, and other protein aggregates, part B. Methods Enzymol. 2006;5(1):223–234.
   Google Scholar
• Ghaemmaghami S, May BC, Renslo AR, et al. Discovery of 2-aminothiazoles as potent antiprion compounds. J Virol. 2010 Apr;84(7):3408–3412.
   PubMed Web of Science ®Google Scholar
• Karapetyan YE, Sferrazza GF, Zhou M, et al. Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents. Proc Natl Acad Sci USA. 2013;110(17):7044–7049.
   PubMed Web of Science ®Google Scholar
• Butler DA, Scott MR, Bockman JM, et al. Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol. 1988;62(5):1558–1564.
   PubMed Web of Science ®Google Scholar
• Klöhn PC, Stoltze L, Flechsig E, et al. A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc Natl Acad Sci USA. 2003;100(20):11666–11671.
   PubMed Web of Science ®Google Scholar
• Mahal SP, Baker CA, Demczyk CA, et al. Prion strain discrimination in cell culture: the cell panel assay. Proc Natl Acad Sci USA. 2007;104(52):20908–20913.
   PubMed Web of Science ®Google Scholar
• Lehmann S. Prion propagation in cell culture. Methods Mol Biol. 2005;299(ii):227–234.
   PubMedGoogle Scholar
• Vilette D, Andreoletti O, Archer F, et al. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc Natl Acad Sci USA. 2001;98(7):4055–4059.
   PubMed Web of Science ®Google Scholar
• Courageot MP, Daude N, Nonno R, et al. A cell line infectible by prion strains from different species. J Gen Virol. 2008;89(1):341–347.
   PubMedGoogle Scholar
• Bian J, Napier D, Khaychuck V, et al. Cell-based quantification of chronic wasting disease prions. J Virol. 2010 Aug;84(16):8322–8326.
   PubMed Web of Science ®Google Scholar
• Dassanayake RP, Zhuang D, Truscott TC, et al. A transfectant RK13 cell line permissive to classical caprine scrapie prion propagation. Prion. 2016 Mar 3;10(2):153–164.
   PubMed Web of Science ®Google Scholar
• Tark D, Kim H, Neale MH, et al. Generation of a persistently infected MDBK cell line with natural bovine spongiform encephalopathy (BSE). Plos One. 2015;10(2):e0115939.
   PubMed Web of Science ®Google Scholar
• Courageot MP, Daude N, Nonno R, et al. A cell line infectible by prion strains from different species. J Gen Virol. 2008 Jan;89(Pt 1):341–347.
   PubMedGoogle Scholar
• Bian J, Napier D, Khaychuck V, et al. Cell-based quantification of chronic wasting disease prions. J Virol. 2010;84(16):8322–8326.
   PubMed Web of Science ®Google Scholar
• Bourkas MEC, Arshad H, Al-Azzawi ZAM, et al. Engineering a murine cell line for the stable propagation of hamster prions. J Biol Chem. 2019 Mar 29;294(13):4911–4923.
   PubMed Web of Science ®Google Scholar
• Walia R, Ho CC, Lee C, et al. Gene-edited murine cell lines for propagation of chronic wasting disease prions. Sci Rep. 2019Aug 1;9(1):11151.
   PubMed Web of Science ®Google Scholar
• Johnson C, Johnson J, Vanderloo JP, et al. Prion protein polymorphisms in white-tailed deer influence susceptibility to chronic wasting disease. J Gen Virol. 2006 Jul;87(Pt 7):2109–2114.
   PubMedGoogle Scholar
• Hannaoui S, Amidian S, Cheng YC, et al. Destabilizing polymorphism in cervid prion protein hydrophobic core determines prion conformation and conversion efficiency. Plos Pathog. 2017 Aug;13(8):e1006553.
   PubMed Web of Science ®Google Scholar
• Taylor DM. Inactivation of prions by physical and chemical means. J Hosp Infect. 1999;43:S69–76.
   PubMed Web of Science ®Google Scholar
• Avar M, Heinzer D, Steinke N, et al. Prion infection, transmission, and cytopathology modeled in a low-biohazard human cell line. Life Sci Alliance. 2020 Aug;3(8):e202000814.
   PubMed Web of Science ®Google Scholar
• Pease D, Scheckel C, Schaper E, et al. Genome-wide identification of microRNAs regulating the human prion protein. Brain Pathol. 2019 Mar;29(2):232–244.
   PubMed Web of Science ®Google Scholar
• Kaur G, Dufour JM. Cell lines. Spermatogenesis. 2012;2(1):1–5.
   PubMedGoogle Scholar
• Herbst A, Banser P, Velasquez CD, et al. Infectious prions accumulate to high levels in non proliferative C2C12 myotubes. Plos Pathog. 2013;9(11):e1003755.
   PubMed Web of Science ®Google Scholar
• Fang C, Imberdis T, Garza MC, et al. A neuronal culture system to detect prion synaptotoxicity. Plos Pathog. 2016 May;12(5):e1005623.
   PubMed Web of Science ®Google Scholar
• Mallucci GR. Prion neurodegeneration: starts and stops at the synapse. Prion. 2009 Oct-Dec;3(4):195–201.
   PubMed Web of Science ®Google Scholar
• Benilova I, Reilly M, Terry C, et al. Highly infectious prions are not directly neurotoxic. Proc Natl Acad Sci USA. 2020 Sept 22;117(38):23815–23822.
   PubMed Web of Science ®Google Scholar
• Schwenke KA, Walzlein JH, Bauer A, et al. Primary glia cells from bank vole propagate multiple rodent-adapted scrapie prions. Sci Rep. 2022 Feb 9;12(1):2190.
   PubMed Web of Science ®Google Scholar
• Nonno R, Di Bari MA, Cardone F, et al. Efficient transmission and characterization of Creutzfeldt-Jakob disease strains in bank voles. Plos Pathog. 2006 Feb;2(2):e12.
   PubMed Web of Science ®Google Scholar
• Hannaoui S, Gougerot A, Privat N, et al. Cycline efficacy on the propagation of human prions in primary cultured neurons is strain-specific. J Infect Dis. 2014 Apr 1;209(7):1144–1148.
   PubMed Web of Science ®Google Scholar
• Walzlein JH, Schwenke KA, Beekes M. Propagation of CJD prions in primary murine glia cells expressing human PrP(c). Pathogens. 2021Aug 20;10(8):1060.
   PubMed Web of Science ®Google Scholar
• Hannaoui S, Maatouk L, Privat N, et al. Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type. J Virol. 2013 Mar;87(5):2535–2548.
   PubMed Web of Science ®Google Scholar
• Teruya K, Doh-Ura K. Insights from therapeutic studies for PrP prion disease. Cold Spring Harb Perspect Med. 2017;7(3):1–18.
   Web of Science ®Google Scholar
• de Rus Jacquet A, Denis HL, Cicchetti F, et al. Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders. Mol Psychiatry. 2021;26(7):2685–2706.
   PubMed Web of Science ®Google Scholar
• Krejciova Z, Alibhai J, Zhao C, et al., Human stem cell-derived astrocytes replicate human prions in a PRNP genotype-dependent manner. J Exp Med. 2017;214(12): 3481–3495.
   PubMed Web of Science ®Google Scholar
• Matamoros-Angles A, Gayosso LM, Richaud-Patin Y, et al. iPS cell cultures from a Gerstmann-Sträussler-Scheinker patient with the y218n prnp mutation recapitulate tau pathology. Mol Neurobiol. 2018;55(4):3033–3048.
   PubMed Web of Science ®Google Scholar
• García‐mendívil L, Mediano DR, Hernaiz A, et al. Effect of scrapie prion infection in ovine bone marrow‐derived mesenchymal stem cells and ovine mesenchymal stem cell‐derived neurons. Animals. 2021;11(4):1137.
   Web of Science ®Google Scholar
• Pineau H, V S. POSCAbilities: the application of the prion organotypic slice culture assay to neurodegenerative disease research. Biomolecules. 2020 Jul 20;10(7):1079.
   PubMed Web of Science ®Google Scholar
• Gogolla N, Galimberti I, DePaola V, et al. Preparation of organotypic hippocampal slice cultures for long-term live imaging. Nat Protoc. 2006;1(3):1165–1171.
   PubMed Web of Science ®Google Scholar
• Falsig J, Julius C, Margalith I, et al. A versatile prion replication assay in organotypic brain slices. Nat Neurosci. 2008 Jan;11(1):109–117.
   PubMed Web of Science ®Google Scholar
• Dr SBPMSPCBSDFGABDEDKABBAHM, Cochran SP, Groth DF. Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol. 1982;11(4):353–358.
   PubMed Web of Science ®Google Scholar
• Wolf H, Hossinger A, Fehlinger A, et al. Deposition pattern and subcellular distribution of disease-associated prion protein in cerebellar organotypic slice cultures infected with scrapie. Front Neurosci. 2015;9:410.
   PubMed Web of Science ®Google Scholar
• Falsig J, Sonati T, Herrmann US, et al. Prion pathogenesis is faithfully reproduced in cerebellar organotypic slice cultures. Plos Pathog. 2012;8(11):e1002985.
   PubMed Web of Science ®Google Scholar
• Margalith I, Suter C, Ballmer B, et al. Polythiophenes inhibit prion propagation by stabilizing prion protein (PrP) aggregates. J Biol Chem. 2012;287(23):18872–18887.
   PubMed Web of Science ®Google Scholar
• Cortez LM, Campeau J, Norman G, et al. Bile acids reduce prion conversion, reduce neuronal loss, and prolong male survival in models of prion disease. J Virol. 2015;89(15):7660–7672.
   PubMed Web of Science ®Google Scholar
• Goniotaki D, Lakkaraju AKK, Shrivastava AN, et al. Inhibition of group-I metabotropic glutamate receptors protects against prion toxicity. Plos Pathog. 2017 Nov;13(11):e1006733.
   PubMed Web of Science ®Google Scholar
• Bardelli M, Frontzek K, Simonelli L, et al. A bispecific immunotweezer prevents soluble PrP oligomers and abolishes prion toxicity. Plos Pathog. 2018 Oct;14(10):e1007335.
   PubMed Web of Science ®Google Scholar
• Endres K, Mitteregger G, Kojro E, et al. Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo. Neurobiol Dis. 2009 Nov;36(2):233–241.
   PubMed Web of Science ®Google Scholar
• Altmeppen HC, Prox J, Krasemann S, et al. The sheddase ADAM10 is a potent modulator of prion disease. eLife. 2015;2015(4):1–50.
   Google Scholar
• Jarosz-Griffiths HH, Corbett NJ, Rowland HA, et al. Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-beta oligomers. J Biol Chem. 2019 Apr 26;294(17):7085–7097.
   PubMed Web of Science ®Google Scholar
• Linsenmeier L, Mohammadi B, Shafiq M, et al. Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies. Sci Adv. 2021;7(48)
   PubMed Web of Science ®Google Scholar
• Kanthasamy A, Kondru N, Manne S, et al. Integrated organotypic slice cultures and RT-QuIC (OSCAR) assay: implications for translational discovery in protein misfolding diseases. Sci Rep. 2017 Oct;7:1–13.
   PubMed Web of Science ®Google Scholar
• Sherafat A, Hill RA, Nishiyama A. Organotypic slice cultures to study oligodendrocyte proliferation, fate, and myelination. Methods Mol Biol. 2018;1791:145–156.
   PubMedGoogle Scholar
• Hofmann JP, Denner P, Nussbaum-Krammer C, et al. Cell-to-cell propagation of infectious cytosolic protein aggregates. Proc Natl Acad Sci USA. 2013 Apr 9;110(15):5951–5956.
   PubMed Web of Science ®Google Scholar
• Croft CL, Futch HS, Moore BD, et al. Organotypic brain slice cultures to model neurodegenerative proteinopathies. Mol Neurodegener. 2019 Dec 2;14(1):45.
   PubMed Web of Science ®Google Scholar
• Duport S, Robert F, Muller D, et al. An in vitro blood-brain barrier model: cocultures between endothelial cells and organotypic brain slice cultures. Proc Natl Acad Sci USA. 1998;95(4):1840–1845.
   PubMed Web of Science ®Google Scholar
• Qi XR, Verwer RWH, Bao AM, et al. Human brain slice culture: a useful tool to study brain disorders and potential therapeutic compounds. Neurosci Bull. 2019 Apr;35(2):244–252.
   PubMed Web of Science ®Google Scholar
• Tropepe V, Hitoshi S, Sirard C, et al. Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron. 2001;30(1):65–78.
   PubMed Web of Science ®Google Scholar
• Jensen JB, Parmar M. Strengths and limitations of the neurosphere culture system. Mol Neurobiol. 2006;34(3):153–161.
   PubMed Web of Science ®Google Scholar
• Giri RK, Young R, Pitstick R, et al. Prion infection of mouse neuropheres. Proc Natl Acad Sci USA. 2006;103(10):3875–3880.
   PubMed Web of Science ®Google Scholar
• Herva ME, Relaño-Ginés A, Villa A, et al., Prion infection of differentiated neurospheres. J Neurosci Methods. 2010;188(2): 270–275.
   PubMed Web of Science ®Google Scholar
• Iwamaru Y, Takenouchi T, Imamura M, et al. Prion replication elicits cytopathic changes in differentiated neurosphere cultures. J Virol. 2013;87(15):8745–8755.
   PubMed Web of Science ®Google Scholar
• Iwamaru Y, Mathiason CK, Telling GC, et al. Chronic wasting disease prion infection of differentiated neurospheres. Prion. 2017;11(4):277–283.
   PubMed Web of Science ®Google Scholar
• Relaño-Ginès A, Gabelle A, Hamela C, et al. Prion replication occurs in endogenous adult neural stem cells and alters their neuronal fate: involvement of endogenous neural stem cells in prion diseases. Plos Pathog. 2013;9(8):e1003485.
   PubMed Web of Science ®Google Scholar
• Bajsarowicz K, Ahn M, Ackerman L, et al., A brain aggregate model gives new insights into the pathobiology and treatment of prion diseases. J Neuropathol Exp Neurol. 2012;71(5): 449–466.
   PubMed Web of Science ®Google Scholar
• Spilman P, Lessard P, Sattavat M, et al. A γ-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains. Proc Natl Acad Sci USA. 2008;105(30):10595–10600.
   PubMed Web of Science ®Google Scholar
• Ahn M, Kalume F, Pitstick R, et al. Brain aggregates: an effective in vitro cell culture system modeling neurodegenerative diseases. J Neuropathol Exp Neurol. 2016;75(3):256–262.
   PubMed Web of Science ®Google Scholar
• Huch M, Koo BK. Modeling mouse and human development using organoid cultures. Development. 2015 Sept 15; 142(18):3113–3125.
   PubMed Web of Science ®Google Scholar
• Groveman BR, Foliaki ST, Orru CD, et al. Sporadic Creutzfeldt-Jakob disease prion infection of human cerebral organoids. Acta Neuropathol Commun. 2019;7(1):90.
   PubMed Web of Science ®Google Scholar
• Hartley BJ, Brennand KJ. Neural organoids for disease phenotyping, drug screening and developmental biology studies. Neurochem Int. 2017 Jun;106:85–93.
   PubMed Web of Science ®Google Scholar
• Groveman BR, Foliaki ST, Orru CD, et al. Sporadic Creutzfeldt-Jakob disease prion infection of human cerebral organoids. Acta Neuropathol Commun. 2019 Jun 14;7(1):90.
   PubMed Web of Science ®Google Scholar
• Renner H, Becker KJ, Kagermeier TE, et al. Cell-type-specific high throughput toxicity testing in human midbrain organoids. Front Mol Neurosci. 2021;14:715054.
   PubMed Web of Science ®Google Scholar
• Dekkers JF, Berkers G, Kruisselbrink E, et al. Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis. Sci Transl Med. 2016;8(344):344ra84.
   PubMed Web of Science ®Google Scholar
• Groveman BR, Ferreira NC, Foliaki ST, et al. Human cerebral organoids as a therapeutic drug screening model for Creutzfeldt-Jakob disease. Sci Rep. 2021 Mar 9;11(1):5165.
   PubMed Web of Science ®Google Scholar
• Caughey B, Raymond GJ. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol. 1993;67(2):643–650.
   PubMed Web of Science ®Google Scholar
• Doh-ura K, Ishikawa K, Murakami-Kubo I, et al. Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models. J Virol. 2004 May;78(10):4999–5006.
   PubMed Web of Science ®Google Scholar
• Terada T, Tsuboi Y, Obi T, et al. Less protease-resistant PrP in a patient with sporadic CJD treated with intraventricular pentosan polysulphate. Acta Neurol Scand. 2010 Feb;121(2):127–130.
   PubMed Web of Science ®Google Scholar
• Hofer M, Lutolf MP. Engineering organoids. Nat Rev Mater. 2021;6(5):402–420.
   PubMed Web of Science ®Google Scholar
• Wörsdörfer P, T I, Asahina I, et al. Do not keep it simple: recent advances in the generation of complex organoids. J Neural transm. 2020;127(11):1569–1577.
   PubMed Web of Science ®Google Scholar
• Zhao X, Xu Z, Xiao L, et al. Review on the vascularization of organoids and organoids-on-a-chip. Front Bioeng Biotechnol. 2021;9:637048.
   PubMed Web of Science ®Google Scholar
• Kryndushkin D, Edskes HK, Shewmaker FP, et al. Prions. Cold Spring Harb Protoc. 2017;2017(2):98–104.
   Google Scholar
• Jossé L, Marchante R, Zenthon J, et al. Probing the role of structural features of mouse PrP in yeast by expression as Sup35-PrP fusions. Prion. 2012;6(3):201–210.
   PubMed Web of Science ®Google Scholar
• Hartwell LH. Yeast and cancer. Bioscience Rep. 2004;24(4–5):523–544.
   PubMed Web of Science ®Google Scholar
• Bach S, Talarek N, Andrieu T, et al. Isolation of drugs active against mammalian prions using a yeast-based screening assay. Nat Biotechnol. 2003;21(9):1075–1081.
   PubMed Web of Science ®Google Scholar
• Jennings LK, Robertson LP, Rudolph KE, et al. Anti-prion butenolides and diphenylpropanones from the Australian ascidian polycarpa procera. J Nat Prod. 2019;82(9):2620–2626.
   PubMed Web of Science ®Google Scholar
• Du Z, Goncharoff DK, Cheng X, et al. Analysis of [SWI+] formation and propagation events. Mol Microbiol. 2017;104(1):105–124.
   PubMed Web of Science ®Google Scholar
• Du Z, Valtierra S, Cardona LR, et al. Identifying anti-prion chemical compounds using a newly established yeast high-throughput screening system. Cell Chem Biol. 2019;26(12):1664–1680.e4.
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Lisiecki K. Anti-prion drug screening system in Saccharomyces cerevisiae based on an artificial [LEU2+] prion. Fungal Genet Biol. 2020;134:103280.
   PubMed Web of Science ®Google Scholar
• Tribouillard-Tanvier D, Béringue V, Desban N, et al. Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions. PLos ONE. 2008;3(4):e1981.
   PubMed Web of Science ®Google Scholar
• Jennings LK, Ahmed I, Munn AL, et al. Yeast-based screening of natural product extracts results in the identification of prion inhibitors from a marine sponge. Prion. 2018;12(3–4):234–244.
   PubMed Web of Science ®Google Scholar
• Fiore NJ, Ganat YM, Devkota K, et al. Bioengineered models of Parkinson’s disease using patient-derived dopaminergic neurons exhibit distinct biological profiles in a 3D microenvironment. Cell Mol Life Sci. 2022 Jan 19;79(2):78.
   PubMed Web of Science ®Google Scholar